▶ 調査レポート

クラッベ病治療の世界市場（～2026年）
• 英文タイトル：Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。クラッベ病治療の世界市場（～2026年） / Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY12467資料のイメージです。• レポートコード：MRC2-11QY12467
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別クラッベ病治療の競争状況、市場シェア
・世界のクラッベ病治療市場：種類別市場規模 2015年-2020年（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）
・世界のクラッベ病治療市場：種類別市場規模予測 2021年-2026年（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）
・世界のクラッベ病治療市場：用途別市場規模 2015年-2020年（病院、ASC）
・世界のクラッベ病治療市場：用途別市場規模予測 2021年-2026年（病院、ASC）
・北米のクラッベ病治療市場分析：米国、カナダ
・ヨーロッパのクラッベ病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのクラッベ病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のクラッベ病治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのクラッベ病治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：GlaxoSmithKline、Johnson & Johnson、Novartis
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessive pattern.
Although there is no known cure for Krabbe disease, bone marrow transplantation has been shown to benefit cases early in the course of the disease. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation. Cord blood transplants have been successful in stopping the disease as long as they are given before overt symptoms appear.

Market Analysis and Insights: Global Krabbe Disease Treatment Market
The global Krabbe Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Krabbe Disease Treatment Scope and Market Size
Krabbe Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Krabbe Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GlaxoSmithKline
Johnson & Johnson
Novartis
…

Market segment by Type, the product can be split into
Anticonvulsants
Muscle Relaxants
HSCT
Others
Market segment by Application, split into
Hospitals
ASCs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Krabbe Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Krabbe Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticonvulsants
1.4.3 Muscle Relaxants
1.4.4 HSCT
1.4.5 Others
1.5 Market by Application
1.5.1 Global Krabbe Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 ASCs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Krabbe Disease Treatment Market Perspective (2015-2026)
2.2 Global Krabbe Disease Treatment Growth Trends by Regions
2.2.1 Krabbe Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Krabbe Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Krabbe Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Krabbe Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Krabbe Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Krabbe Disease Treatment Players by Market Size
3.1.1 Global Top Krabbe Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Krabbe Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Krabbe Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Krabbe Disease Treatment Market Concentration Ratio
3.2.1 Global Krabbe Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Krabbe Disease Treatment Revenue in 2019
3.3 Krabbe Disease Treatment Key Players Head office and Area Served
3.4 Key Players Krabbe Disease Treatment Product Solution and Service
3.5 Date of Enter into Krabbe Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Krabbe Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Krabbe Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Krabbe Disease Treatment Market Size by Application (2015-2020)
5.2 Global Krabbe Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Krabbe Disease Treatment Market Size (2015-2020)
6.2 Krabbe Disease Treatment Key Players in North America (2019-2020)
6.3 North America Krabbe Disease Treatment Market Size by Type (2015-2020)
6.4 North America Krabbe Disease Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Krabbe Disease Treatment Market Size (2015-2020)
7.2 Krabbe Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Krabbe Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Krabbe Disease Treatment Market Size by Application (2015-2020)

8 China
8.1 China Krabbe Disease Treatment Market Size (2015-2020)
8.2 Krabbe Disease Treatment Key Players in China (2019-2020)
8.3 China Krabbe Disease Treatment Market Size by Type (2015-2020)
8.4 China Krabbe Disease Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Krabbe Disease Treatment Market Size (2015-2020)
9.2 Krabbe Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Krabbe Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Krabbe Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Krabbe Disease Treatment Market Size (2015-2020)
10.2 Krabbe Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Krabbe Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Krabbe Disease Treatment Market Size by Application (2015-2020)

11 India
11.1 India Krabbe Disease Treatment Market Size (2015-2020)
11.2 Krabbe Disease Treatment Key Players in India (2019-2020)
11.3 India Krabbe Disease Treatment Market Size by Type (2015-2020)
11.4 India Krabbe Disease Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Krabbe Disease Treatment Market Size (2015-2020)
12.2 Krabbe Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Krabbe Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Krabbe Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Krabbe Disease Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Krabbe Disease Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Krabbe Disease Treatment Introduction
13.2.4 Johnson & Johnson Revenue in Krabbe Disease Treatment Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Krabbe Disease Treatment Introduction
13.3.4 Novartis Revenue in Krabbe Disease Treatment Business (2015-2020)
13.3.5 Novartis Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Krabbe Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Krabbe Disease Treatment Revenue
Table 3. Ranking of Global Top Krabbe Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Krabbe Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticonvulsants
Table 6. Key Players of Muscle Relaxants
Table 7. Key Players of HSCT
Table 8. Key Players of Others
Table 9. Global Krabbe Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Krabbe Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Krabbe Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Krabbe Disease Treatment Market Share by Regions (2015-2020)
Table 13. Global Krabbe Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Krabbe Disease Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Krabbe Disease Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Krabbe Disease Treatment Players
Table 20. Global Krabbe Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Krabbe Disease Treatment Market Share by Players (2015-2020)
Table 22. Global Top Krabbe Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Krabbe Disease Treatment as of 2019)
Table 23. Global Krabbe Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Krabbe Disease Treatment Product Solution and Service
Table 26. Date of Enter into Krabbe Disease Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Krabbe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Krabbe Disease Treatment Market Size Share by Type (2015-2020)
Table 30. Global Krabbe Disease Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Krabbe Disease Treatment Market Size Share by Application (2015-2020)
Table 32. Global Krabbe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Krabbe Disease Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Krabbe Disease Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Krabbe Disease Treatment Market Share (2019-2020)
Table 36. North America Krabbe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Krabbe Disease Treatment Market Share by Type (2015-2020)
Table 38. North America Krabbe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Krabbe Disease Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Krabbe Disease Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Krabbe Disease Treatment Market Share (2019-2020)
Table 42. Europe Krabbe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Krabbe Disease Treatment Market Share by Type (2015-2020)
Table 44. Europe Krabbe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Krabbe Disease Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Krabbe Disease Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Krabbe Disease Treatment Market Share (2019-2020)
Table 48. China Krabbe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Krabbe Disease Treatment Market Share by Type (2015-2020)
Table 50. China Krabbe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Krabbe Disease Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Krabbe Disease Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Krabbe Disease Treatment Market Share (2019-2020)
Table 54. Japan Krabbe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Krabbe Disease Treatment Market Share by Type (2015-2020)
Table 56. Japan Krabbe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Krabbe Disease Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Krabbe Disease Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Krabbe Disease Treatment Market Share (2019-2020)
Table 60. Southeast Asia Krabbe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Krabbe Disease Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Krabbe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Krabbe Disease Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Krabbe Disease Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Krabbe Disease Treatment Market Share (2019-2020)
Table 66. India Krabbe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Krabbe Disease Treatment Market Share by Type (2015-2020)
Table 68. India Krabbe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Krabbe Disease Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Krabbe Disease Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Krabbe Disease Treatment Market Share (2019-2020)
Table 72. Central & South America Krabbe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Krabbe Disease Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Krabbe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Krabbe Disease Treatment Market Share by Application (2015-2020)
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Revenue in Krabbe Disease Treatment Business (2015-2020) (Million US$)
Table 80. GlaxoSmithKline Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Krabbe Disease Treatment Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Krabbe Disease Treatment Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Krabbe Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Anticonvulsants Features
Figure 3. Muscle Relaxants Features
Figure 4. HSCT Features
Figure 5. Others Features
Figure 6. Global Krabbe Disease Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. ASCs Case Studies
Figure 9. Krabbe Disease Treatment Report Years Considered
Figure 10. Global Krabbe Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Krabbe Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Krabbe Disease Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Krabbe Disease Treatment Market Share by Players in 2019
Figure 15. Global Top Krabbe Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Krabbe Disease Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Krabbe Disease Treatment Revenue in 2019
Figure 17. North America Krabbe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Krabbe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Krabbe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Krabbe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Krabbe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Krabbe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Krabbe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介
  • クラッベ病治療薬の世界市場（～2026年）
    Global Krabbe Disease Drugs Market Size, Status and Forecast 2020-2026
    MRC2-11QY12466 2020年11月25日 94Pages
    当調査資料はクラッベ病治療薬のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、その他）市場規模、用途別（病院、クリニック、研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...
  • 人獣共通感染症治療の世界市場（～2026年）
    Global Zoonotic Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY05134 2020年11月20日 93Pages
    当調査資料は人獣共通感染症治療のグローバル市場について調査・分析したレポートです。種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...
  • キャッスルマン病治療の世界市場（～2026年）
    Global Castleman Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11288 2020年11月25日 93Pages
    当調査資料はキャッスルマン病治療のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、化学療法、放射線療法、免疫療法、コルチコステロイド、抗ウイルス薬）市場規模、用途別（病院、臨床、外来診療ユニット）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...
  • 希少神経疾患治療の世界市場（～2026年）
    Global Rare Neurological Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04460 2020年11月20日 98Pages
    当調査資料は希少神経疾患治療のグローバル市場について調査・分析したレポートです。種類別（生物製剤、有機化合物）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...
  • 炎症性腸疾患（IBD）治療の世界市場（～2026年）
    Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12375 2020年11月25日 95Pages
    当調査資料は炎症性腸疾患（IBD）治療のグローバル市場について調査・分析したレポートです。種類別（TNF阻害剤、アミノサリチル酸塩、免疫調節剤、コルチコステロイド）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...
  • 希少疾患治療の世界市場（～2026年）
    Global Rare Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04458 2020年11月20日 129Pages
    当調査資料は希少疾患治療のグローバル市場について調査・分析したレポートです。種類別（オリジネーター医薬品、ジェネリック医薬品）市場規模、用途別（病院薬局、専門薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...
  • ニューカッスル病治療の世界市場（～2026年）
    Global Newcastle Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY03968 2020年11月20日 99Pages
    当調査資料はニューカッスル病治療のグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...
  • クッシング病治療の世界市場（～2026年）
    Global Cushing’s Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11540 2020年11月25日 99Pages
    当調査資料はクッシング病治療のグローバル市場について調査・分析したレポートです。種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局）市場規模、地域...
  • 感染症治療の世界市場（～2026年）
    Global Infectious Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12367 2020年11月25日 91Pages
    当調査資料は感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗真菌薬、抗ウイルス薬）市場規模、用途別（病院・クリニック、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...
  • レイノー病治療の世界市場（～2026年）
    Global Raynauds Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04462 2020年11月20日 91Pages
    当調査資料はレイノー病治療のグローバル市場について調査・分析したレポートです。種類別（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...
  • クラッベ病治療薬の世界市場（～2026年）クラッベ病治療薬の世界市場（～2026年） Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
  • ニューカッスル病治療の世界市場（～2026年）ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
  • 感染症治療の世界市場（～2026年）感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…
  • クッシング病治療の世界市場（～2026年）クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
  • 人獣共通感染症治療の世界市場（～2026年）人獣共通感染症治療の世界市場（～2026年） Zoonotic Disease is directly transmitted from animals to humans through media such as air (influenza) or through bites and saliva (rabies). Market Analysis and Insights: Global Zoonotic Disease Treatment Market The global Zoonotic Disease Treatment market size is projected to reach US$ XX million by…